{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:27:57Z","timestamp":1786512477371,"version":"build-2736575974"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>We report a rare case of Diffuse Midline Glioma, H3K27-altered, arising in a non-midline fronto-temporo-insular location in a 48-year-old adult, initially mimicking Glioblastoma, IDH-wildtype, based on radiology and histopathology. Integrated molecular diagnostics, including genome-wide DNA methylation profiling and Sanger sequencing, confirmed an H3.3 K27M mutation, while Nanopore-based methylation profiling provided a rapid and fully concordant classification, demonstrating the feasibility of real-time epigenomic diagnostics in clinical practice. H3K27M-mutant diffuse non-midline gliomas (DNMG) are extremely rare, with only ~39 cases reported in the literature, most commonly involving the temporal lobe and associated with poor prognosis. Our case highlights that DNMGs can present in adults and in previously unreported hemispheric locations, underscoring the importance of integrated molecular testing not only for accurate diagnosis but also to guide patient management and enable enrollment in potential targeted therapies. Molecular profiling thus represents a critical tool for personalized treatment planning and prognostic assessment in these uncommon gliomas.<\/jats:p>","DOI":"10.3389\/fonc.2026.1897287","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:40:40Z","timestamp":1786509640000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanopore and EPIC array profiling unmask an atypical non-midline H3 K27-altered glioma: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Michela","family":"Buonaiuto","sequence":"first","affiliation":[{"name":"CEINGE-Advanced Biotechnologies \u201cFranco Salvatore\u201d","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"Giordano","sequence":"additional","affiliation":[{"name":"U.O.C. Oncologia, Ospedale del Mare, Azienda Ospedaliera Locale (ASL NA1) Centro","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"D\u2019Avino","sequence":"additional","affiliation":[{"name":"U.O.C. Anatomia Patologica, Ospedale del Mare, Azienda Ospedaliera Locale (ASL NA 1) Centro","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Affinito","sequence":"additional","affiliation":[{"name":"AREA Science Park","place":["Trieste, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Cuomo","sequence":"additional","affiliation":[{"name":"CEINGE-Advanced Biotechnologies \u201cFranco Salvatore\u201d","place":["Napoli, Italy"]},{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Napoli \u201cFederico II\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sabbarese","sequence":"additional","affiliation":[{"name":"CEINGE-Advanced Biotechnologies \u201cFranco Salvatore\u201d","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Viggiano","sequence":"additional","affiliation":[{"name":"U.O.C. Oncologia, Ospedale del Mare, Azienda Ospedaliera Locale (ASL NA1) Centro","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Maria","family":"Giugliano","sequence":"additional","affiliation":[{"name":"U.O.C. Radioterapia, Ospedale del Mare, ASL NA1 Centro","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Negro","sequence":"additional","affiliation":[{"name":"U.O.C. Neuroradiologia, Ospedale del Mare, Azienda Ospedaliera Locale (ASL NA1) Centro","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Frio","sequence":"additional","affiliation":[{"name":"U.O.C. Neurochirurgia, Ospedale del Mare, Azienda Ospedaliera Locale (ASL NA1) Centro","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Catapano","sequence":"additional","affiliation":[{"name":"U.O.C. Neurochirurgia, Ospedale del Mare, Azienda Ospedaliera Locale (ASL NA1) Centro","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Chiariotti","sequence":"additional","affiliation":[{"name":"CEINGE-Advanced Biotechnologies \u201cFranco Salvatore\u201d","place":["Napoli, Italy"]},{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Napoli \u201cFederico II\u201d","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Della Monica","sequence":"additional","affiliation":[{"name":"CEINGE-Advanced Biotechnologies \u201cFranco Salvatore\u201d","place":["Napoli, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3892\/or.2026.9055","article-title":"Epigenetic mechanisms and therapeutic advances in diffuse midline glioma (review)","volume":"55","author":"Wu","year":"2026","journal-title":"Oncol Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100931","article-title":"Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma","volume":"44","author":"Sharma","year":"2023","journal-title":"Neoplasia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-830","article-title":"Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO classification","volume":"114","author":"Gianno","year":"2022","journal-title":"Pathologica"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-022-04024-5","article-title":"Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity","volume":"158","author":"L\u00f3pez-P\u00e9rez","year":"2022","journal-title":"J Neuro-Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34381","article-title":"Epigenetic alterations in glioblastomas: diagnostic, prognostic and therapeutic relevance","volume":"153","author":"Montella","year":"2023","journal-title":"Int J Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13148-025-01980-3","article-title":"Multiple functions of the lysine methyltransferase KMT5a in cancer: potential targets for innovative therapies","volume":"17","author":"Della Monica","year":"2025","journal-title":"Clin Epigenet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1477978","article-title":"Case report: Rare intraventricular H3 K27-altered diffuse midline glioma in an adult","volume":"15","author":"Jasso","year":"2025","journal-title":"Front Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.humpath.2018.04.015","article-title":"H3 K27M-mutant diffuse midline gliomas in different anatomical locations","volume":"78","author":"Wang","year":"2018","journal-title":"Hum Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab135","article-title":"H3K27M-mutant, hemispheric diffuse glioma in an adult patient with prolonged survival","volume":"3","author":"Chia","year":"2021","journal-title":"Neuro-Oncol Adv"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04733-z","article-title":"Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location","volume":"169","author":"Guidara","year":"2024","journal-title":"J Neuro-Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","article-title":"Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma","volume":"22","author":"Sturm","year":"","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","article-title":"Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma","volume":"46","author":"Fontebasso","year":"","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma","volume":"32","author":"Mackay","year":"","journal-title":"Cancer Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40478-017-0440-x","article-title":"Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma","volume":"5","author":"Schwartzentruber","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40478-017-0440-x","article-title":"Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma","volume":"5","author":"L\u00f3pez","year":"","journal-title":"Acta Neuropathol Commun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/jnen\/nlac016","article-title":"Beyond Midline: Diffuse Hemispheric Glioma, H3 K27M-Mutant with Aggressive Behavior","volume":"81","author":"Val\u00e9rio","year":"","journal-title":"J Neuropathol Exp Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.neucie.2021.06.008","article-title":"Molecular and clinical characterization of H3 K27M-mutant \"non-midline\" glioblastoma: A case report and literature review","volume":"33","author":"Onishi","year":"","journal-title":"Neurocirug\u00eda (Engl Ed)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3171\/2019.9.JNS191920","article-title":"Imaging characteristics of adult H3 K27M-mutant gliomas","volume":"133","author":"Qiu","year":"","journal-title":"J Neurosurg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"37112","DOI":"10.18632\/oncotarget.2643","article-title":"Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes","volume":"9","author":"Huang","year":"","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1093\/neuonc\/noae021","article-title":"Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort","volume":"26","author":"Odia","year":"","journal-title":"Neuro Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jnen\/nlae018","article-title":"Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?","volume":"83","author":"Donev","year":"","journal-title":"J Neuropathol Exp Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00401-014-1338-3","article-title":"A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas","volume":"128","author":"Venneti","year":"","journal-title":"Acta Neuropathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/neuonc\/noaf103","article-title":"ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumor diagnosis","volume":"27","author":"Deacon","year":"","journal-title":"Neuro Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1093\/neuonc\/noae031","article-title":"ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma","volume":"26","author":"Arrillaga-Romany","year":"","journal-title":"Neuro Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1897287\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T04:40:54Z","timestamp":1786509654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1897287\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":26,"alternative-id":["10.3389\/fonc.2026.1897287"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1897287","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1897287"}}